A global CRO, Medpace is strategically mapped to support clinical studies around the world.
Medpace has the global reach to conduct studies in biopharmaceuticals and medical device around the world.
We help deliver custom solutions specific to your needs on six continents. Projects are facilitated
through regional offices located throughout Europe, Asia, Australia, South Africa, and the Americas,
with staff and offices continually added throughout the world.
Integrated clinical trial services from
our wholy-owned business units including Clinical Pharmacology,
Central Laboratory, Imaging, and Bioanalytical provide efficient global trial conduct from discovery to post marketing.
Medpace experts have a deep understanding of local language, culture, and processes, creating better relationships with investigators and improved trial execution. They have greater access to the country patient populations for faster enrollment timelines and lower costs.
The Medpace expanding global footprint is interconnected through our innovative suite of technologies, ClinTrak®, which gives sponsors and study managers real-time access to critical study data, supporting project decisions on a global level.